Samsung Medical Center
Multiple sclerosis treatment cost in South Korea runs from AUD $21,034 to AUD $50,046 for yearly medication, while a brain MRI with contrast costs between AUD $1,015 and AUD $1,741. Total expenses depend on the therapy stage, required infusions, and rehabilitation needs. Patients typically save 60–80% compared to Australia and the US. Seoul and Incheon are the primary hubs for this care.
Typical Multiple Sclerosis Treatment Costs in South Korea
Bookimed Expert Insight: For patients needing rapid diagnostics, Seoul National University Hospital uses an electronic medical records system to coordinate care efficiently. Complex cases requiring intensive physical therapy gain most value at Severance Hospital, which has a dedicated rehabilitation department. Those exploring innovative options can access arterial stem cell delivery at RE:YOUTH, the only Korean clinic providing this targeted method for organ-specific treatment.
| Republic of Korea | Thailand | Turkey | |
| Plasmapheresis | from AUD $6,093 | from AUD $3,191 | from AUD $1,741 |
| Ocrevus (ocrelizumab) | from AUD $26,401 | from AUD $29,012 | from AUD $14,506 |
| Multiple sclerosis rehabilitation | from AUD $22,049 | from AUD $2,901 | from AUD $4,352 |
| Medication treatment for multiple sclerosis | from AUD $21,034 | from AUD $4,352 | from AUD $3,627 |
| Therapeutic Apheresis | - | - | from AUD $1,958 |
No hidden fees – just official clinic prices. Pay at the clinic for Multiple sclerosis treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Multiple sclerosis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Multiple sclerosis treatment journey.
Professor Kwang Ho Lee is a senior neurology specialist at Samsung Medical Center – one of South Korea's most prestigious university hospitals.
Dr. Byung-hee Lee is a neurosurgeon at RE:YOUTH Clinic in South Korea. He is a founding member of the Korean Society of Interventional Neurology. He also helped found the Korean Stroke Society. Dr. Lee treats complex conditions like Parkinson's, Alzheimer's, and cerebral aneurysms.
Professor Kim Seung Min leads clinical care for complex neurological cases at Severance Hospital – one of South Korea's most prestigious medical centres.
South Korea offers high-quality multiple sclerosis care featuring specialised diagnostics and disease-modifying therapies. Treatment centres in Seoul provide JCI-accredited facilities and digital medical records. This compares well with Australia's specialist neurologists. However, Korea offers additional options like arterial stem cell therapy at specialised clinics.
Bookimed Expert Insight: South Korea's leadership in digital health helps international patients. Facilities like Seoul National University Bundang Hospital use the BESTcare digital system to reduce medical errors. This integration simplifies sharing MRI scans and treatment reports with Australian GPs for follow-up care.
Patient Consensus: Patients note that quality depends on finding an experienced neurologist and securing detailed English treatment summaries. Success in Korea often involves choosing clinics that provide MRI results and clear medication handovers for local Australian doctors.
South Korean clinics provide over 11 disease-modifying therapies (DMTs) approved by the Ministry of Food and Drug Safety. Specialists at JCI-accredited hubs like Severance Hospital offer high-efficacy infusions including Ocrevus and Tysabri. Neurological diagnostics integrate MRI and Visual Evoked Potentials (VEP) to monitor disease progression.
Bookimed Expert Insight: South Korea specialises in high-volume neurological care. Severance Hospital alone manages 4,000,000 patients annually. This scale allows doctors like Dr Kim Seung Min to participate in global clinical trials. Patients benefit from doctors who see many complex neurodegenerative cases.
Autologous Haematopoietic Stem Cell Transplant (AHSCT) is a specialised option for aggressive multiple sclerosis in South Korea. Major JCI-accredited hospitals in Seoul provide this immune-rebooting procedure. The process involves harvesting stem cells and intensive chemotherapy. This happens under strict Ministry of Food and Drug Safety regulations.
Bookimed Expert Insight: South Korea is known for major hospitals, but clinics like RE:YOUTH limit intake. They see only 2 patients daily. This focus allows for intensive monitoring that high-volume hospitals may not provide. Samsung Medical Center handles over 2,000,000 cases annually. This offers massive clinical depth for complex immunological reboots.
Patient Consensus: Patients say it is essential to distinguish between stem cell injections and full HSCT. Many suggest confirming that neurology and haematology teams work together in Seoul.
South Korean hospitals manage acute multiple sclerosis relapses using high-dose intravenous steroids and plasmapheresis within JCI-accredited facilities. Specialists typically prescribe 1,000 mg of methylprednisolone daily for 3–5 days to reduce inflammation. Clinics in Seoul also provide specialised neuro-rehabilitation to restore function after neurological deficits.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital consistently rank in Newsweek's World’s Best Hospitals. These centres serve 2,000,000 to 4,000,000 patients annually. This massive case volume means neurologists like Dr Kwang Ho Lee manage complex relapses daily. For Australians, this level of clinical experience exceeds what is typical in smaller domestic units.
Patient Consensus: Patients find that reaching a major tertiary hospital quickly is vital for urgent steroid treatment. They suggest bringing a symptom timeline and previous MRI scans to speed up the assessment in Korea.
International patients undergoing multiple sclerosis assessment in South Korea follow a structured neurology-led pathway. This typically includes a physical exam, brain MRI with contrast, and specialised testing like lumbar puncture. Diagnostics occur at JCI-accredited Seoul hospitals, often concluding within 1 to 3 weeks.
Bookimed Expert Insight: South Korea's digitised healthcare system provides a distinct advantage for international patients. Clinics like Seoul National University Hospital have been fully digital since 2004. This allows for seamless transfers of high-resolution imaging and reports. Local specialists can review digital history quickly. This often reduces the number of days needed for the initial assessment phase.
Patient Consensus: Patients note the process requires several steps rather than one visit. Bringing prior MRI scans and a clear symptom timeline helps avoid repeating basic tests in Seoul or Incheon.
South Korean specialists provide holistic support by integrating neurology with rehabilitation and multidisciplinary care. Major JCI-accredited hubs like Severance Hospital and Asan Medical Center employ neurology teams. These teams coordinate with rehabilitation specialists to manage symptoms and improve daily quality of life.
Bookimed Expert Insight: While South Korean centres are known for digital efficiency, large university hospitals offer comprehensive support. For example, Severance Hospital serves 4,000,000 patients annually. These institutions house neurology, rehabilitation, and ophthalmology under one roof. This allows medical records to be shared instantly between departments for a unified treatment plan.
Patient Consensus: Patients find Korean medical care exceptionally precise. However, they often need to ask specialists for specific referrals to physiotherapy or nutrition. Many recommend confirming upfront if the neurologist manages the full care team in South Korea.